340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
Environmental scholar Bjorn Lomborg recently calculated that across the globe, governments have spent at least $16 trillion feeding the climate change industrial complex.
And for what?
Arguably, not a single life has been or will be saved by this shameful and colossal misallocation of human resources. The war on safe and abundant fossil fuels has cost countless lives in poor countries and made those countries poorer by blocking affordable energy.
Since the global warming crusade started some 30 years ago, the temperature of the planet has not been altered by one-tenth of a degree – as…
